DR. ROSS BASCH, M.D.
Medical Practice at End Ave, New York, NY
License number
New York 09481
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
205 W End Ave, New York, NY 10023
Phone
(212) 580-2083
(212) 263-0496 (Fax)
(212) 263-0496 (Fax)
Personal information
See more information about ROSS BASCH at radaris.comName
Address
Phone
100 Bleecker St APT 8D, New York, NY 10012
205 W End Ave APT 19C, New York, NY 10023
New York, NY
100 Bleecker St, New York, NY 10012
Organization information
See more information about ROSS BASCH at bizstanding.comRoss Basch MD
205 W End Ave, New York, NY 10023
Industry:
Internist
Phone:
(212) 877-7177 (Phone)
Ross Spencer Basch
New York University Medical Center - Ross Basch MD
550 1 Ave #MSB563, New York, NY 10016
Categories:
Pathology Physicians & Surgeons
Phone:
(212) 263-5344 (Phone)
Professional information
Ross Spencer Basch, New York NY
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Hematology
Work:
Frankel Orthodontics
205 W End Ave, New York, NY 10023 New York University
550 1St Ave, New York, NY 10016
205 W End Ave, New York, NY 10023 New York University
550 1St Ave, New York, NY 10016
Education:
New York University (1961)
Professor Of Pathology At New York University
Position:
Professor of Pathology at New York University
Location:
Greater New York City Area
Industry:
Higher Education
Work:
New York University
-
Professor of Pathology
Dr. Ross Basch, Brooklyn NY - MD (Doctor of Medicine)
Specialties:
Clinical Pathology
Address:
Bendiner Schlesinger Lab
140 58Th St SUITE 8D, Brooklyn 11220
(212) 353-5102 (Phone)
140 58Th St SUITE 8D, Brooklyn 11220
(212) 353-5102 (Phone)
Languages:
English
Hospitals:
Bendiner Schlesinger Lab
140 58Th St SUITE 8D, Brooklyn 11220
Long Island College Hospital
339 Hicks St, Brooklyn 11201
Lutheran Medical Center
150 55Th St, Brooklyn 11220
Metropolitan Hospital Center
1901 1St Ave, New York 10029
140 58Th St SUITE 8D, Brooklyn 11220
Long Island College Hospital
339 Hicks St, Brooklyn 11201
Lutheran Medical Center
150 55Th St, Brooklyn 11220
Metropolitan Hospital Center
1901 1St Ave, New York 10029
Education:
Medical School
New York University
Graduated: 1961
New York University
Graduated: 1961
C21 Polypeptide That Modulates The Stability Of Transcriptional Regulatory Complexes Regulating Nuclear Hormone Receptor Activity
US Patent:
6982317, Jan 3, 2006
Filed:
Nov 15, 2001
Appl. No.:
09/987701
Inventors:
Ross S. Basch - New York NY, US
Assignee:
New York University - New York NY
International Classification:
C07K 14/47, C07K 16/18
US Classification:
530350, 530300, 530324, 5303871, 5303881, 5303879
Abstract:
A gene in humans and mice, designated C21, encodes a family of proteins that play a role in transcriptional regulation. Two isoforms (α and β) produced by alternative splicing has been identified in humans. A transgenic model was created that shows that over-expression of C21 in mouse hematopoietic cells alters myeloid development and suggests that members of this family are involved in regulating stem cell differentiation. Over-expressing C21 in 3T3 fibroblasts increases their resistance to apoptotic stimuli. The C21 protein forms a complex with a class of molecules that plays a critical role in transcription, the co-repressors of nuclear hormone receptors.
Methods And Compositions For The Growth And Maintenance Of Stem Cells
US Patent:
2006013, Jun 22, 2006
Filed:
Nov 30, 2005
Appl. No.:
11/290626
Inventors:
Ross Basch - New York NY, US
Simon Karpatkin - New York NY, US
Rashmi Gupta - Albertson NY, US
Simon Karpatkin - New York NY, US
Rashmi Gupta - Albertson NY, US
International Classification:
C12N 5/08
US Classification:
435372000
Abstract:
The present invention relates to pluripotent stem cells and methods of promoting long term growth of such cells. In particular, the methods described are used to enhance the proliferation of hematopoietic stem cells, hematopoietic precursor cells, hemangioblasts and endothelial stem cells. The present invention also relates to methods of using such cells, comprising introducing such stem cells, into the host. The present invention also relates to pharmaceutical compositions comprising the cells and such compositions may include growth factors or cytokines to allow for further cell growth and/or cellular differentiation. The invention further relates to methods of in vivo administration of a protein or gene of interest comprising transfecting the stem cells grown by the methods described, with a construct comprising DNA which encodes a protein of interest and then introducing the stem cell into the host where the protein or gene of interest is expressed.
N,N'-Bis(4-Azidobenzoyl)Cystine
US Patent:
4784804, Nov 15, 1988
Filed:
Aug 4, 1986
Appl. No.:
6/894469
Inventors:
Ross S. Basch - New York NY
Michiel E. Ultee - Belle Mead NJ
Michiel E. Ultee - Belle Mead NJ
Assignee:
New York University - New York NY
International Classification:
C07C11708
US Classification:
260349
Abstract:
N,N'-Bis(4-Azidobenzoyl) Cystine useful as photoaffinity labels.